• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

机构信息

Universidad de Marburg, Marburg, Alemania, Miembro del Centro Alemán para Investigación Pulmonar (DZL).

Lewis Katz School of Medicine at Temple University, Filadelfia, Pensilvania, EE. UU.

出版信息

Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6.

DOI:10.1016/j.arbres.2017.02.001
PMID:28274597
Abstract

This Executive Summary of the Global Strategy for the Diagnosis, Management, and Prevention of COPD (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: 1) the assessment of COPD has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; 2) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; 3) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; 4) nonpharmacologic therapies are comprehensively presented and; 5) the importance of comorbid conditions in managing COPD is reviewed.

摘要

这份《2017 年慢性阻塞性肺疾病全球策略诊断、管理和预防执行摘要》主要关注文件的修订和新颖部分。最显著的变化包括:1)对 COPD 的评估进行了细化,将肺功能评估与症状评估分开。现在建议仅根据患者的症状及其加重病史来确定 ABCD 组;2)为 A 至 D 组中的每一组都提出了药物治疗的升级策略;3)在治疗评估方案中引入了治疗降级的概念;4)全面介绍了非药物治疗方法;5)审查了合并症在 COPD 管理中的重要性。

相似文献

1
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。
Arch Bronconeumol. 2017 Mar;53(3):128-149. doi: 10.1016/j.arbres.2017.02.001. Epub 2017 Mar 6.
2
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。
Respirology. 2017 Apr;22(3):575-601. doi: 10.1111/resp.13012. Epub 2017 Mar 7.
3
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.慢性阻塞性肺疾病全球策略:诊断、管理与预防 2017 年报告。GOLD 执行摘要。
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP.
4
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.全球慢性阻塞性肺疾病诊断、管理和预防策略 2017 年报告:GOLD 执行摘要。
Eur Respir J. 2017 Mar 6;49(3). doi: 10.1183/13993003.00214-2017. Print 2017 Mar.
5
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.全球慢性阻塞性肺疾病诊断、管理和预防策略:GOLD 执行摘要。
Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9.
6
The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what?慢性阻塞性肺疾病全球诊断、管理和预防策略(GOLD)2011年修订版——为何修订及修订内容?
Clin Respir J. 2012 Oct;6(4):208-14. doi: 10.1111/crj.12002.
7
Chronic obstructive pulmonary disease - diagnosis and management of stable disease; a personalized approach to care, using the treatable traits concept based on clinical phenotypes. Position paper of the Czech Pneumological and Phthisiological Society.慢性阻塞性肺疾病 - 稳定期疾病的诊断和管理;基于临床表型的可治疗特征概念,采用个体化护理方法。捷克肺病和结核学会立场文件。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Dec;164(4):325-356. doi: 10.5507/bp.2020.056.
8
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.慢性阻塞性肺疾病诊断、管理和预防全球策略:GOLD执行摘要
Am J Respir Crit Care Med. 2007 Sep 15;176(6):532-55. doi: 10.1164/rccm.200703-456SO. Epub 2007 May 16.
9
Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study.根据 2017 年 GOLD 报告对 COPD 患者的分类和对推荐治疗的依从性:RELICO 研究。
BMC Pulm Med. 2021 Jul 9;21(1):216. doi: 10.1186/s12890-021-01576-6.
10
[Concept and management of COPD, from past to future].[慢性阻塞性肺疾病的概念与管理:从过去到未来]
Nihon Rinsho. 2016 May;74(5):723-7.

引用本文的文献

1
Comparison of clinical outcome of COPD with asthma-like feature with different inhalation therapies: a real-world study in the prospective RealDTC cohort.不同吸入疗法治疗具有哮喘样特征的慢性阻塞性肺疾病的临床结局比较:前瞻性RealDTC队列的一项真实世界研究
BMC Pulm Med. 2025 Jul 2;25(1):294. doi: 10.1186/s12890-025-03767-x.
2
Predicting Superaverage Length of Stay in COPD Patients with Hypercapnic Respiratory Failure Using Machine Learning.使用机器学习预测慢性阻塞性肺疾病合并高碳酸血症呼吸衰竭患者的超长住院时间
J Inflamm Res. 2025 May 8;18:5993-6008. doi: 10.2147/JIR.S511092. eCollection 2025.
3
The association between cardiovascular diseases and their subcategories with the severity of chronic obstructive pulmonary disease: a large cross-sectional study based on a Chinese hospital population cohort.
心血管疾病及其亚类与慢性阻塞性肺疾病严重程度之间的关联:一项基于中国医院人群队列的大型横断面研究。
Front Cardiovasc Med. 2025 Feb 13;12:1502205. doi: 10.3389/fcvm.2025.1502205. eCollection 2025.
4
The Perception of Asthma, Chronic Obstructive Pulmonary Disease, Asthma and Chronic Obstructive Pulmonary Disease Overlap, and Cough Variant Asthma: A Retrospective Observational Study.哮喘、慢性阻塞性肺疾病、哮喘与慢性阻塞性肺疾病重叠以及咳嗽变异性哮喘的认知:一项回顾性观察研究。
Intern Med. 2025 Feb 8. doi: 10.2169/internalmedicine.4519-24.
5
Fibrotic and emphysematous murine lung mechanics under negative-pressure ventilation.负压通气下纤维化和肺气肿小鼠的肺力学
Am J Physiol Lung Cell Mol Physiol. 2025 Mar 1;328(3):L443-L455. doi: 10.1152/ajplung.00087.2024. Epub 2025 Jan 15.
6
Association between lipid accumulation product and chronic obstructive pulmonary disease: a cross-sectional analysis.脂质蓄积产物与慢性阻塞性肺疾病的关联:一项横断面分析
BMC Pulm Med. 2025 Jan 6;25(1):6. doi: 10.1186/s12890-024-03465-0.
7
Nomograms for Predicting High Hospitalization Costs and Prolonged Stay among Hospitalized Patients with pAECOPD.预测慢性阻塞性肺疾病急性加重期住院患者高住院费用和延长住院时间的列线图
Can Respir J. 2024 Sep 6;2024:2639080. doi: 10.1155/2024/2639080. eCollection 2024.
8
Curcumin liposomes attenuate the expression of cigarette smoke extract-induced inflammatory markers IL-8 and IL-24 .姜黄素脂质体可减弱香烟烟雾提取物诱导的炎症标志物白细胞介素-8和白细胞介素-24的表达。
EXCLI J. 2024 Jun 12;23:904-907. doi: 10.17179/excli2024-7467. eCollection 2024.
9
Assessing the impact of temperature on acute exacerbation of chronic obstructive pulmonary disease hospitalizations in residents of Panzhihua City: a multi-districts study using a distributed lag non-linear model.评估温度对攀枝花市居民慢性阻塞性肺疾病急性加重住院的影响:一项使用分布滞后非线性模型的多地区研究。
BMC Public Health. 2024 Aug 8;24(1):2151. doi: 10.1186/s12889-024-19677-2.
10
Inflammation mediates the association between furan exposure and the prevalence and mortality of chronic obstructive pulmonary disease: National Health and Nutrition Examination Survey 2013-2018.炎症介导呋喃暴露与慢性阻塞性肺疾病患病率和死亡率之间的关联:2013-2018 年全国健康和营养调查。
BMC Public Health. 2024 Apr 15;24(1):1046. doi: 10.1186/s12889-024-18442-9.